EUVIMEDEUVIMED entdecken
Crossref

Pharmacogenomics In Adverse Drug Reactions: Improving Personalized Drug Safety with New Artificial Intelligence Support - A Review

Vaishnavi B Kadam, Abhirup R Sagare, Prakash D Jadhav, Harshada S Yadav, Vaishnavi M Mahamuni, Akshada S Padalkar, Vaishnavi S Veer

International Journal of Pharmaceutical Sciences Review and Research · 2026-06 · 86 (6)

DOI: 10.47583/ijpsrr.2026.v86i6.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Sciences Review and Research, 2026-06. Verfasst von Vaishnavi B Kadam und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The vital topic of pharmacogenomics explains why different people react differently to the same medicine.While some people respond well to medication, others might need to change their dosage or develop adverse drug reactions (ADRs).Variations in genes linked to drug metabolism, transport, and immune response have been identified as important determinants impacting drug safety and efficacy as research in this field has progressed from researching individual genes to examining the entire genome.ADRs continue to be a significant problem in the healthcare industry, as they can lead to drug failure during development and, in certain situations, withdrawal from the market following approval.Identifying patients at higher risk of ADRs before treatment can significantly improve drug safety and therapeutic outcomes.Regulatory efforts, such as the inclusion of genetic information in drug labeling, are supporting more informed clinical decision-making.In this context, pharmacogenomics plays a crucial role in advancing personalized medicine by enabling safer and more targeted therapies.Additionally, the growing use of artificial intelligence (AI), particularly machine learning (ML), offers new opportunities to predict ADRs by analyzing complex and large-scale data.Despite these advancements, there is still a need for comprehensive evaluation of these models to ensure their accuracy, reliability, and applicability in real-world clinical settings.

Zitieren

APA

Kadam, V. B., Sagare, A. R., Jadhav, P. D., Yadav, H. S., Mahamuni, V. M., Padalkar, A. S., & Veer, V. S. (2026). Pharmacogenomics In Adverse Drug Reactions: Improving Personalized Drug Safety with New Artificial Intelligence Support - A Review. International Journal of Pharmaceutical Sciences Review and Research, 86(6). https://doi.org/10.47583/ijpsrr.2026.v86i6.021

Vancouver

Kadam VB, Sagare AR, Jadhav PD, Yadav HS, Mahamuni VM, Padalkar AS, et al. Pharmacogenomics In Adverse Drug Reactions: Improving Personalized Drug Safety with New Artificial Intelligence Support - A Review. International Journal of Pharmaceutical Sciences Review and Research. 2026;86(6). doi:10.47583/ijpsrr.2026.v86i6.021

BibTeX
@article{Kadam2026,
  author = {Kadam, Vaishnavi B and Sagare, Abhirup R and Jadhav, Prakash D and Yadav, Harshada S and Mahamuni, Vaishnavi M and Padalkar, Akshada S and Veer, Vaishnavi S},
  title = {Pharmacogenomics In Adverse Drug Reactions: Improving Personalized Drug Safety with New Artificial Intelligence Support - A Review},
  journal = {International Journal of Pharmaceutical Sciences Review and Research},
  year = {2026},
  volume = {86},
  number = {6},
  doi = {10.47583/ijpsrr.2026.v86i6.021}
}
Kostenlos starten →